13 Analysts Have This To Say About Elevance Health
13 Analysts Have This To Say About Elevance Health
13位分析师对Elevance Health发表了如下评论:
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $600.08, along with a high estimate of $643.00 and a low estimate of $530.00. A negative shift in sentiment is evident as analysts have decreased the average price target by...13 analysts have expressed a variety of opinions on Elevance Health (NYSE:ELV) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在过去的一个季度里，有13位分析师对Elevance Health (纽交所:ELV) 发表了各种不同的观点，从看好到看淡，观点纷呈。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表提供了分析师最近的评级概述，为了全面了解过去30天的情绪变化并与前几个月进行比较，提供了深入的见解。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $600.08, along with a high estimate of $643.00 and a low estimate of $530.00. A negative shift in sentiment is evident as analysts have decreased the average price target by...
Providing deeper insights, analysts have ...
登录免费看全文
登录/注册
资讯热榜
更新时间